Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases

Oncogene volume 20, pages 6607–6616 (2001)Cite this article

Abstract

The actin filament-associated protein of 110 kDa (AFAP-110) is a Src binding partner that represents a potential modulator of actin filament integrity in response to cellular signals. Previous reports have demonstrated that AFAP-110 is capable of directly binding and altering actin filaments. Deletion of the leucine zipper motif of AFAP-110 (AFAP-110Δlzip) has been shown to induce a phenotype which resembles Src-transformed cells, by repositioning actin filaments into rosettes. This deletion also mimics a conformational change in AFAP-110 that is detected in Src-transformed cells. The results presented here indicate that unlike AFAP-110, AFAP-110Δlzip is capable of activating cellular tyrosine kinases, including Src family members, and that AFAP-110Δlzip itself is hyperphosphorylated. The newly tyrosine phosphorylated proteins and activated Src-family members appear to be associated with actin-rich lamellipodia. A point mutation that alters the SH3-binding motif of AFAP-110Δlzip prevents it from activating tyrosine kinases and altering actin filament integrity. In addition, a deletion within a pleckstrin homology (PH) domain of AFAP-110Δlzip will also revert its effects upon actin filaments. Lastly, dominant-positive RhoAV14 will block the ability of AFAP-110Δlzip from inducing actin filament rosettes, but does not inhibit Src activation. Thus, conformational changes in AFAP-110 enable it to activate cellular kinases in a mechanism requiring SH3 and/or PH domain interactions. We hypothesize that cellular signals which alter AFAP-110 conformation, enable it to activate cellular kinases such as cSrc, which then direct changes in actin filament integrity in a Rho-dependent fashion.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Baisden JM, Qian Y, Zot HM, Flynn DC . 2001 Oncogene in press

  • Bolen JB, Veillette A, Schwartz AM, DeSeau V, Rosen N . 1987 Proc. Natl. Acad. Sci. USA 84: 2251–2255

  • Boschek CB, Jockusch BM, Friis RR, Back R, Grundmann E, Bauer H . 1981 Cell 24: 175–184

  • Boyle WJ, van der GP, Hunter T . 1991 Methods Enzymol. 201: 110–149

  • Briggs SD, Sharkey M, Stevenson M, Smithgall TE . 1997 J. Biol. Chem. 272: 17899–17902

  • Brown MT, Cooper JA . 1996 Biochim. Biophys. Acta 1287: 121–149

  • Cartwright CA, Meisler AI, Eckhart W . 1990 Proc. Natl. Acad. Sci. USA 87: 558–562

  • Felice GR, Eason P, Nermut MV, Kellie S . 1990 Eur. J. Cell Biol. 52: 47–59

  • Fincham VJ, Chudleigh A, Frame MC . 1999 J Cell Sci. 112: Pt 6 947–956

  • Flynn DC, Leu TH, Reynolds AB, Parsons JT . 1993 Mol. Cell Biol. 13: 7892–7900

  • Guappone AC, Flynn DC . 1997 Mol. Cell Biochem. 175: 243–252

  • Guappone AC, Weimer T, Flynn DC . 1998 Mol. Carcinog. 22: 110–119

  • Hamaguchi M, Hanafusa H . 1987 Proc. Natl. Acad. Sci. USA 84: 2312–2316

  • He H, Hirokawa Y, Levitzki A, Maruta H . 2000 Cancer J 6: 243–248

  • Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R, Yeatman TJ . 1999 Nat. Genet. 21: 187–190

  • Kanner SB, Reynolds AB, Wang HC, Vines RR, Parsons JT . 1991 EMBO J. 10: 1689–1698

  • Liu X, Pawson T . 1994 Recent Prog. Horm. Res. 49: 149–160

  • Mayer T, Meyer M, Janning A, Schiedel AC, Barnekow A . 1999 Oncogene 18: 2117–2128

  • Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee CH, Kuriyan J, Miller WT . 1997 Nature 385: 650–653

  • Qian Y, Baisden JM, Westin EH, Guappone AC, Koay TC, Flynn DC . 1998 Oncogene 16: 2185–2195

  • Qian Y, Guappone AC, Baisden JM, Hill MW, Summy J, Flynn DC . 1999 Hybridoma 18: 167–175

  • Qian Y, Baisden JM, Zot HG, Van Winkle WB, Flynn DC . 2000 Exp. Cell Res. 255: 102–113

  • Reynolds AB, Kanner SB, Wang HC, Parsons JT . 1989 Mol. Cell Biol. 9: 3951–3958

  • Ridley AJ, Hall A . 1992 Cell 70: 389–399

  • Rosen N, Bolen JB, Schwartz AM, Cohen P, DeSeau V, Israel MA . 1986 J. Biol. Chem. 261: 13754–13759

  • Sabe H, Okada M, Nakagawa H, Hanafusa H . 1992 Mol. Cell Biol. 12: 4706–4713

  • Schwartzberg PL, Xing L, Hoffmann O, Lowell CA, Garrett L, Boyce BF, Varmus HE . 1997 Genes Dev. 11: 2835–2844

  • Tarone G, Cirillo D, Giancotti FG, Comoglio PM, Marchisio PC . 1985 Exp. Cell Res. 159: 141–157

  • Thomas JW, Ellis B, Boerner RJ, Knight WB, White GC, Schaller MD . 1998 J Biol. Chem. 273: 577–583

  • Xing L, Ge C, Zeltser R, Maskevitch G, Mayer BJ, Alexandropoulos K . 2000 Mol. Cell Biol. 20: 7363–7377

Download references

Acknowledgements

Thanks to Ray Mattingly, Wayne State University for the dominant-positive RhoAV14 constructs. This work was supported by a grant from the NCI (to DC Flynn), CA60731. JM Baisden was supported by a grant from the West Virginia University Medical Scientist Training Program.

Author information

Authors and Affiliations

  1. Department of Microbiology & Immunology, 2822 MBRCC, West Virginia University, Morgantown, WV 26506-9300, West Virginia, USA

    Joseph M Baisden, Amanda S Gatesman, Lidia Cherezova & Daniel C Flynn

  2. Department of Microbiology & Immunology, 1820 MBRCC, West Virginia University, Morgantown, WV 26506-9300, West Virginia, USA

    Bing-Hua Jiang

Authors
  1. Joseph M Baisden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amanda S Gatesman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lidia Cherezova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bing-Hua Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Daniel C Flynn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel C Flynn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baisden, J., Gatesman, A., Cherezova, L. et al. The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases. Oncogene 20, 6607–6616 (2001). https://doi.org/10.1038/sj.onc.1204802

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204802

Keywords

This article is cited by

Search

Advanced search

Quick links